Tags

Type your tag names separated by a space and hit enter

The symptoms, neurobiology, and current pharmacological treatment of depression.
J Neurosci Nurs. 2005 Apr; 37(2):102-7.JN

Abstract

Depression as a medical disorder increasingly is being recognized and treated. The mood of an individual with major depression is often described as sad, hopeless, or discouraged, and there are many physical symptoms associated with depression. Pharmacologic treatments for depression have advanced greatly since the development of the first therapies, monoamine oxidase inhibitors (MAOIs). Many medications, such as tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and serotonin norepinephrine reuptake inhibitors (SNRIs), currently are available to help combat this health problem. Newer medications have eliminated many of the side effects associated with older therapies, and treatments in development are designed with the goal of further improving on efficacy while eliminating side effects.

Authors+Show Affiliations

IntraMed Educational Group, 230 Park Avenue South, New York, NY 10003, USA. sto1967@aol.comNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

15902953

Citation

To, Stephen E., et al. "The Symptoms, Neurobiology, and Current Pharmacological Treatment of Depression." The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses, vol. 37, no. 2, 2005, pp. 102-7.
To SE, Zepf RA, Woods AG. The symptoms, neurobiology, and current pharmacological treatment of depression. J Neurosci Nurs. 2005;37(2):102-7.
To, S. E., Zepf, R. A., & Woods, A. G. (2005). The symptoms, neurobiology, and current pharmacological treatment of depression. The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses, 37(2), 102-7.
To SE, Zepf RA, Woods AG. The Symptoms, Neurobiology, and Current Pharmacological Treatment of Depression. J Neurosci Nurs. 2005;37(2):102-7. PubMed PMID: 15902953.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The symptoms, neurobiology, and current pharmacological treatment of depression. AU - To,Stephen E, AU - Zepf,Robert A, AU - Woods,Alisa G, PY - 2005/5/21/pubmed PY - 2005/6/21/medline PY - 2005/5/21/entrez SP - 102 EP - 7 JF - The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses JO - J Neurosci Nurs VL - 37 IS - 2 N2 - Depression as a medical disorder increasingly is being recognized and treated. The mood of an individual with major depression is often described as sad, hopeless, or discouraged, and there are many physical symptoms associated with depression. Pharmacologic treatments for depression have advanced greatly since the development of the first therapies, monoamine oxidase inhibitors (MAOIs). Many medications, such as tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and serotonin norepinephrine reuptake inhibitors (SNRIs), currently are available to help combat this health problem. Newer medications have eliminated many of the side effects associated with older therapies, and treatments in development are designed with the goal of further improving on efficacy while eliminating side effects. SN - 0888-0395 UR - https://www.unboundmedicine.com/medline/citation/15902953/The_symptoms_neurobiology_and_current_pharmacological_treatment_of_depression_ L2 - http://www.diseaseinfosearch.org/result/2199 DB - PRIME DP - Unbound Medicine ER -